Cancer10.1002/(sici)1097-0142(19980301)82:5<931::aid-cncr19>;2-11998825931-935Cost minimization analysis and utility of pretreatment and posttreatment total body iodine-131 scans in patients with thyroid carcinomaPerry Grigsby;2-1,;2-1
Clinical Endocrinology10.1111/j.1365-2265.2011.04278.x2012765734-740Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawalMartin H. Cherk, Peter Francis, Duncan J. Topliss, Michael Bailey, Victor Kalff,
Thyroid10.1089/thy.2009.15822009198811-813The Case for Obtaining a Diagnostic Whole-Body Scan Prior to Iodine 131 Treatment of Differentiated Thyroid CancerI. Ross Mcdougall
Annales d'Endocrinologie10.1016/j.ando.2013.05.0072013743221-230False-positive Iodine-131 whole-body scan findings in patients with differentiated thyroid carcinoma: Report of 11 cases and review of the literatureLeckzinscka Buton, Olivier Morel, Patricia Gault, Frédéric Illouz, Patrice Rodien, Vincent Rohmer,
European Journal of Nuclear Medicine10.1007/bf002381231994219The role of technetium-99m sestamibi whole-body scans in diagnosing metastatic Hurthle cell carcinoma of the thyroid gland after total thyroidectomy: a comparison with iodine-131 and thallium-201 whole-body scansTzu-Chen Yen, Hong-Dar Line, Chen-Hsen Lee, Shu-Liam Change, Shin-Hwa Yeh,,
International Journal of Surgery10.1016/j.ijsu.2015.02.016201516107-112Sensitivity of preparation with rhTSH or thyroid hormone withdrawal using 131 I-whole body scans to identify metastases of differentiated thyroid cancerK. Liepe,
Thyroid10.1089/thy.2005.0085200717181-82False Positive Uptake in Post-treatment Iodine-131 Whole-Body Scans Secondary to ContaminationJonathan Schlosser, Maria Paliou, Rafael Bravo-Vera, Arsalan Sheikh, Alina Gouller
The American Journal of Medicine10.1016/0002-9343(81)90368-51981715806-814The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancerMichael W. Ashcraft, Andre J. Van Herle,
Thyroid10.1089/thy.2008.0339200919101093-1098Utility of the Radioiodine Whole-Body Retention at 48 Hours for Modifying Empiric Activity of 131-Iodine for the Treatment of Metastatic Well-Differentiated Thyroid CarcinomaDouglas Van Nostrand, Frank Atkins, Shari Moreau, Martha Aiken, Kanchan Kulkarni, Jingshu S. Wu, Kenneth D. Burman, Leonard Wartofsky,
Thyroid10.1089/thy.2008.04192009198849-855The Utility of Radioiodine Scans Prior to Iodine 131 Ablation in Patients with Well-Differentiated Thyroid CancerDouglas Van Nostrand, Martha Aiken, Frank Atkins, Shari Moreau, Carlos Garcia, Elmo Acio, Kenneth Burman, Leonard Wartofsky